ProductsBack/Goat anti-LRRK2 / PARK8 (near C Terminus) Antibody

Goat anti-LRRK2 / PARK8 (near C Terminus) Antibody

Name: Goat anti-LRRK2 / PARK8 (near C Terminus) Antibody
SKU: EB06550_100ug_E85
Availability: BackOrder

EB06550

ApplicationsImmunoFluorescence, ELISA

Product group Antibodies

ReactivityHuman

TargetLRRK2

Product EB06550 is not available

Product not available

There may be an alternative product available, please contact our technical support team.

Overview

Supplier
Everest Biotech
Product Name
Goat anti-LRRK2 / PARK8 (near C Terminus) Antibody
Delivery Days Customer
7
Application Supplier Note
Immunofluorescence: Strong expression of the protein seen in the vesicles of A431 cells and in the vesicles and nuclei of A549 cells. Recommended concentration: 10microg/ml.
Applications
ImmunoFluorescence, ELISA
Applications Supplier
Pep-ELISA, IF
Certification
Research Use Only
Clonality
Polyclonal
Concentration
0.5 mg/ml
Gene ID120892
Target name
LRRK2
Target description
leucine rich repeat kinase 2
Target synonyms
AURA17, DARDARIN, PARK8, RIPK7, ROCO2, leucine-rich repeat serine/threonine-protein kinase 2, augmented in rheumatoid arthritis 17
Host
Goat
Scientific Description
RefSeq number(s): NP_940980.3. Purification: Antigen affinity purified. Names and symbols: LRRK2; PARK8; ROCO2; FLJ45829; DKFZp434H2111; leucine-rich repeat kinase 2; dardarin; Parkinson disease (autosomal dominant) 8; AURA17; DARDARIN; RIPK7; augmented in rheumatoid arthritis 17
Reactivity
Human
Reactivity Supplier
Human
Storage Instruction
-20°C
UNSPSC
12352203

Sharma S, Bandopadhyay R, Lashley T, et al. LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study. Neuropathol Appl Neurobiol. 2011,37(7):777-90. doi: 10.1111/j.1365-2990.2011.01187.x
Read this paper
Alegre-Abarrategui J, Christian H, Lufino MM, et al. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum Mol Genet. 2009,18(21):4022-34. doi: 10.1093/hmg/ddp346
Read this paper
Alegre-Abarrategui J, Ansorge O, Esiri M, et al. LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease. Neuropathol Appl Neurobiol. 2008,34(3):272-83.
Read this paper